AMYT Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: Chiesi

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

3 years ago - By: Amryt Pharma plc

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

3 years ago - By: Amryt Pharma plc

Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici

3 years ago - By: The Motley Fool

Why Shares of Amryt Pharma Jumped This Week

3 years ago - By: Benzinga - Mentions: ARWR CERS CUTR RVNC ...

12 Health Care Stocks Moving In Monday's Intraday Session

3 years ago - By: Benzinga - Mentions: DXCM LIXT VYGR ALBO ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

3 years ago - By: Halper Sadeh LLC

AMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to Shareholders

3 years ago - By: Kahn Swick & Foti, LLC

AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT

3 years ago - By: Amryt Pharma plc

Amryt Announces New Patent for Mycapssa®

3 years ago - By: Amryt Pharma plc

AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023

3 years ago - By: Kahn Swick & Foti, LLC

AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT

3 years ago - By: Halper Sadeh LLC

AMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to Shareholders

3 years ago - By: InvestorPlace - Mentions: CINC AZN APGN ALBO ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

3 years ago - By: Seeking Alpha

Chiesi Farmaceutici S.p.A. to acquire Amryt Pharma (NASDAQ:AMYT)

3 years ago - By: Amryt Pharma plc

Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc

3 years ago - By: Amryt Pharma plc

Amryt Announces Positive Top Line Results from Phase 3 Pediatric Trial of Lomitapide in HoFH

3 years ago - By: Amryt Pharma plc

COMP Adopts Positive Opinion on Orphan Designation for Mycapssa® for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors

3 years ago - By: Amryt Pharma plc

AMRYT PHARMA PLC - SPNR ADR (AMYT) Stock News

AMYT Latest News, Press Relases and Analysis

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici

Why Shares of Amryt Pharma Jumped This Week

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

AMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to Shareholders

AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT

Amryt Announces New Patent for Mycapssa®

AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023

AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT

AMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to Shareholders

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Chiesi Farmaceutici S.p.A. to acquire Amryt Pharma (NASDAQ:AMYT)

Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc

Amryt Announces Positive Top Line Results from Phase 3 Pediatric Trial of Lomitapide in HoFH

COMP Adopts Positive Opinion on Orphan Designation for Mycapssa® for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors

European Commission approves Mycapssa® for the treatment of Acromegaly